Cleared Traditional

K820440 - EMIT-AMD AMIKACIN CONTR. (ENZYME IMMUNO (FDA 510(k) Clearance)

Mar 1982
Decision
26d
Days
Class 2
Risk

K820440 is an FDA 510(k) clearance for the EMIT-AMD AMIKACIN CONTR. (ENZYME IMMUNO. This device is classified as a Enzymatic Radiochemical Assay, Amikacin (Class II - Special Controls, product code LDN).

Submitted by Syva Co. (Mchenry, US). The FDA issued a Cleared decision on March 15, 1982, 26 days after receiving the submission on February 17, 1982.

This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3035.

Submission Details

510(k) Number K820440 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 17, 1982
Decision Date March 15, 1982
Days to Decision 26 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary

Device Classification

Product Code LDN — Enzymatic Radiochemical Assay, Amikacin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 862.3035